> ImmunoQure and Memo Therapeutics entered into a collaboration to create libraries from APS-1 memory B cells. The partners think the research will advance work on autoantibodies. Statement
> BioMed X cleared a milestone in the Alzheimer’s disease project it initiated with AbbVie, triggering a milestone payment from the major U.S. biopharma company. Release
> SeraNovo teamed up with Carna Biosciences to develop an oral kinase inhibitor. The partnership will make use of SeraNovo’s formulation platform. Statement
> The FDA cleared ObsEva to start enrolling women undergoing embryo transfer following in vitro fertilization in a phase 3 trial. The trial will test oral oxytocin receptor antagonist nolasiban. Release
> Futura Medical shared additional data on its topical treatment for erectile dysfunction. Statement